BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Baraldi O, Valentini C, Donati G, Comai G, Cuna V, Capelli I, Angelini ML, Moretti MI, Angeletti A, Piscaglia F, Manna GL. Hepatorenal syndrome: Update on diagnosis and treatment. World J Nephrol 2015; 4(5): 511-520 [PMID: 26558188 DOI: 10.5527/wjn.v4.i5.511]
URL: https://www.wjgnet.com/2220-6124/full/v4/i5/511.htm
Number Citing Articles
1
Sondes Bizid, Haythem Yacoub, Ghanem Mohamed, Bahaa Ben Slimane, Khouloud Boughoula, Hatem Ben Abdallah, Riadh Bouali, Nabil Abedelli, Yu-Chen Fan. Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/1134744
2
Jeffrey DellaVolpe, Ali Al-Khafaji. Acute Kidney Injury Before and After Liver TransplantJournal of Intensive Care Medicine 2019; 34(9): 687 doi: 10.1177/0885066618790558
3
Gaetano Bertino, Graziella Privitera, Francesco Purrello, Shirin Demma, Emanuele Crisafulli, Luisa Spadaro, Nikolaos Koukias, Emmanuel A. Tsochatzis. Emerging hepatic syndromes: pathophysiology, diagnosis and treatmentInternal and Emergency Medicine 2016; 11(7): 905 doi: 10.1007/s11739-016-1478-7
4
Tsung-Hsing Hung, Chen-Chi Tsai, Chih-Wei Tseng, Kuo-Chih Tseng, Yu-Hsi Hsieh, Chih-Chun Tsai. No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairmentEuropean Journal of Gastroenterology & Hepatology 2016; 28(11): 1275 doi: 10.1097/MEG.0000000000000703
5
Sanjana Rao, Christopher J. Peterson, Marawan Elmassry, Busara Songtanin, Juthipong Benjanuwattra, Kenneth Nugent. Spontaneous peritoneal drainage following paracentesis in a hospitalized patient with resolution of type 1 hepatorenal syndromeThe American Journal of the Medical Sciences 2022; 364(6): 789 doi: 10.1016/j.amjms.2022.06.016
6
Arjun Nanda, Rewanth Reddy, Humaira Safraz, Habeeb Salameh, Ashwani K. Singal. Pharmacological Therapies for Hepatorenal SyndromeJournal of Clinical Gastroenterology 2018; 52(4): 360 doi: 10.1097/MCG.0000000000000913
7
Juan Carlos Q. Velez, Terrance J. Wickman, Kasra Tayebi, Muner MB. Mohamed, Adil Yousuf, Swetha R. Kanduri, Ivo Lukitsch, Derek Vonderhaar, Karthik Kovvuru, Cathy Wentowski. Addition of a Loop Diuretic to Norepinephrine During Treatment of Hepatorenal Syndrome Type 1Kidney International Reports 2024;  doi: 10.1016/j.ekir.2024.11.013
8
Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil. Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or olderAnnals of Hepatology 2023; 28(5): 101126 doi: 10.1016/j.aohep.2023.101126
9
So Mi Kim, Il Han Song. Acute Kidney Injury in Cirrhotic Patients with Portal HypertensionThe Korean Journal of Gastroenterology 2016; 68(5): 237 doi: 10.4166/kjg.2016.68.5.237
10
Umberto Cillo, Wolf O. Bechstein, Gabriela Berlakovich, Philipp Dutkowski, Frank Lehner, Silvio Nadalin, Faouzi Saliba, Hans J. Schlitt, Johann Pratschke. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppressionTransplantation Reviews 2018; 32(3): 142 doi: 10.1016/j.trre.2018.04.001
11
Zachary David Levy. Absolute Neurocritical Care Review2023; : 157 doi: 10.1007/978-3-031-24830-6_7
12
Santhosh Raja Thangaraj, Mirra Srinivasan, Hadia Arzoun, Siji S Thomas. A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved DrugCureus 2023;  doi: 10.7759/cureus.42367
13
Pascal H. Colson, Anne Virsolvy, Philippe Gaudard, Azzouz Charrabi, Maithé Corbani, Maxime J. Manière, Sylvain Richard, Gilles Guillon. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profilePharmacological Research 2016; 113: 257 doi: 10.1016/j.phrs.2016.08.027
14
M. B. Toledano, S. K. Mukherjee, J. Howell, D. Westaby, S. A. Khan, D. Bilton, N. J. Simmonds, Pavel Strnad. The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide studyPLOS ONE 2019; 14(4): e0212779 doi: 10.1371/journal.pone.0212779
15
Brit Long, Michael Gottlieb. Emergency medicine updates: Spontaneous bacterial peritonitisThe American Journal of Emergency Medicine 2023; 70: 84 doi: 10.1016/j.ajem.2023.05.015
16
Lei Feng, Guolin He, Lei Cai, Chaoyi Fu, Yang Li, Jun Weng, Xiaolin Huo, Qing Peng, Yi Gao. Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical StudyBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7456898
17
Sermsiri Sangroongruangsri, Kankamon Kittrongsiri, Phunchai Charatcharoenwitthaya, Abhasnee Sobhonslidsuk, Usa Chaikledkaew. Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal SyndromeClinicoEconomics and Outcomes Research 2021; : 703 doi: 10.2147/CEOR.S317390
18
Premal S. Trivedi, Matthew A. Brown, Paul J. Rochon, Robert K. Ryu, D. Thor Johnson. Gender Disparity in Inpatient Mortality After Transjugular Intrahepatic Portosystemic Shunt Creation in Patients Admitted With Hepatorenal Syndrome: A Nationwide StudyJournal of the American College of Radiology 2020; 17(2): 231 doi: 10.1016/j.jacr.2019.08.020
19
Maureen Banigan, Julie C. Fitzgerald. Fundamentals of Pediatric Surgery2022; : 135 doi: 10.1007/978-3-031-07524-7_14
20
Natasha Shah, Rogelio G. Silva, Andrew Kowalski, Chaitanya Desai, Edgar Lerma. Hepatorenal syndromeDisease-a-Month 2016; 62(10): 364 doi: 10.1016/j.disamonth.2016.05.009
21
Michael P. Curry, Hugo E. Vargas, Alex S. Befeler, Nikolaos T. Pyrsopoulos, Vilas R. Patwardhan, Khurram Jamil. Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studiesHepatology Communications 2023; 7(1): e1307 doi: 10.1097/01.HC9.0000897228.91307.0c
22
Keiko Hosohata, Ayaka Inada, Saki Oyama, Kazunori Iwanaga. Advances in Nephropathy2018;  doi: 10.5772/intechopen.79348
23
P. Muriel, E. Fernández-Martínez, S. Montes. Liver Pathophysiology2017; : 427 doi: 10.1016/B978-0-12-804274-8.00033-3
24
Daniel Backenroth, Herbert Chase, Carol Friedman, Ying Wei, Jinn-Moon Yang. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug ReactionsPLOS ONE 2016; 11(10): e0164304 doi: 10.1371/journal.pone.0164304
25
Chiara Donadei, Andrea Angeletti, Maria Cappuccilli, Massimiliano Conti, Diletta Conte, Fulvia Zappulo, Alessio De Giovanni, Deborah Malvi, Rita Aldini, Aldo Roda, Gaetano La Manna. Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver CirrhosisJournal of Clinical Medicine 2022; 11(3): 636 doi: 10.3390/jcm11030636
26
H. Rehman, S. T. Rehman, S. Zulfiqar, S. Awan, Shahab Abid. Real-world comparison of terlipressin vs. octreotide as an adjuvant treatment in the management of variceal bleedingScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56873-x
27
Joseph DiNorcia, Steven D. Colquhoun. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set2019; : 1410 doi: 10.1016/B978-0-323-40232-3.00120-5
28
Zachary David Levy. Absolute Neurocritical Care Review2017; : 49 doi: 10.1007/978-3-319-64632-9_2